Page 26 - Vaccine

Lilly Covid-19 treatment could be authorised by September: Chief Scientist

Lilly has already launched human trials with two of the experimental therapies

Panacea forms JV with Refana to develop, manufacture Covid-19 vaccine

The firm is set to make 500 million doses of the vaccine, which will then be supplied to the JV (based in the Republic of Ireland).

Gilead's remdesivir slows disease progression in monkeys with Covid-19

Remdesivir did not show signs of respiratory disease and had reduced damage to the lungs

What are antibody therapies and who is developing them for Covid-19?

Eli Lilly is collaborating with Junshi and Canadian biotech firm AbCellera Biologics to develop different antibody treatments

World coronavirus dispatch: Work on vaccine globalised like never before

From how lockdown has changed human behavior, to New Zealand becoming Covid-free, and how coronavirus devastated the diamond world - read these and more in today's world dispatch

World Coronavirus Dispatch: Is Brazil trying to hide the true toll numbers?

Meanwhile, India enters the list of top 5 infected nations; European airlines set to resume operations

India coronavirus dispatch: How Covid spreads from a contaminated surface

From five lessons India should learn from the crisis, to state of sport post-Covid, read these and more in today's India dispatch

WHO finally endorses masks to prevent transmission

Since the beginning of the pandemic, surprisingly, the WHO had refused to endorse masks

Serum Institute risks making Covid vaccine before trial at new $100 mn unit

AstraZeneca deal with SII is for supply of a billion doses, with a commitment to provide 400 mn before 2020-end. If all goes well, India could have its first set of Covid-19 vaccines by end of year

India joins global alliance to support vaccine supply, immunisation

Gavi's routine immunisation efforts, including during the course of the coronavirus pandemic, help stop the spread of infectious diseases and the resurgence of other epidemics

Steep death graph, no peak yet: Why India is behind the curve on Covid-19

While the mortality rate seems to be plateauing in UK , Spain and Italy after peaking, in India he bad news is that it hasn't reached the high point after which it can start tapering off

India simplifies clinical trial rules for Covid-19 vaccine manufacturing

Govt will take inter-departmental approach to ensure right vaccine candidate is available for Indians at the earliest

CEPI to grant $14 mn for trial of Bharat Biotech's Chikungunya vaccine

The vaccine completed standard pre-clinical studies, and an optimum immune response was elicited by the adjuvant vaccine in phase-1 trials in India

Covid-19 vaccine development moving positively, says Bharat Biotech CEO

He expressed satisfaction on the progress of the research connected with the vaccine development so far, but insisted that "in science, things can change"

Gilead's remdesivir shows modest improvement in moderate Covid-19 patients

At day 11, around 76% of the patients in the 5-day treatment group showed improvement in clinical status versus 66% for standard care alone, Gilead said

WHO, 37 countries launch alliance to share tools to battle Covid-19

The WHO issued a "Solidarity Call to Action", asking other stakeholders to join the voluntary push.

Vaccine for Covid-19 will take long time to be ready: Kiran Mazumdar-Shaw

The quickest for any vaccine to be prepared is not less than four years, says Kiran Mazumdar-Shaw.

Sun Pharma to test two drugs for treatment of Covid-19, stock up 3.5%

At present there are three clinical trials underway to test nafamostat in Covid19 patients around the world

30 groups in India working on coronavirus vaccine, 20 at 'good pace'

ICMR conducting study on presence of antibodies in people, results next week

GSK to produce 1 billion doses of coronavirus vaccine booster in 2021

The British drugmaker is working on its own COVID vaccine with Sanofi